Some studies have shown that decreased topoisomerase levels in relapsed tumors contribute to the tumor resistance [9, 10]; additionally, researchers also found that there is a compensatory effect between top1 and top2α: when the expression of one type of topisomerase is decreased, the other will be increased [9, 11–13]. This evidence concerns the gene TOP2A and neoplasm.